EMEA: Concept paper on the revision of the guideline on Radiopharmaceuticals based on Monoclonal Antibodies

The revision of the Guideline on Radiopharmaceuticals Based on Monoclonal Antibodies will focus on quality aspects encompassing both monoclonal antibodies and radiopharmaceutical aspects and will be done so as to ensure consistency and complementarity with the above-mentioned revised guidelines on monoclonal antibodies and on radiopharmaceuticals.